Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Opinion Editor's Corner

The Biggest News of 2020: TCTMD’s Top 10

Shelley Wood

December 28, 2020

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Clinical Trial Conduct in the COVID-19 Era: A Road Map

Todd Neale

November 12, 2020

News Conference News HFSA 2020

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

L.A. McKeown

October 12, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Conference News HFSA 2020

EMBRACE HF: Empagliflozin Cuts PA Pressure in HF With or Without Diabetes

L.A. McKeown

October 09, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

As Interventions Dip During COVID-19, CMS Offers Leniency on Volumes

Todd Neale

September 23, 2020

News Daily News

In MITRA-FR, ‘Disproportionate’ MR Theory Doesn’t Pan Out

Shelley Wood

September 18, 2020

News Daily News

James T. Willerson, Revered Clinician, Editor, and Mentor, Dies at 81

L.A. McKeown

September 18, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2020

Shelley Wood

July 31, 2020

News Daily News

Too Many HF Trial Results Underreported or Never Published

L.A. McKeown

June 23, 2020

News Conference News TVT 2020

MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT

Michael O'Riordan

June 21, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2020

Shelley Wood

March 02, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2020

Shelley Wood

January 31, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Opinion Editor's Corner

The Biggest News of 2019: TCTMD’s Top 10

Shelley Wood

January 01, 2020

Advertisement

The Biggest News of 2020: TCTMD’s Top 10

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Clinical Trial Conduct in the COVID-19 Era: A Road Map

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

EMBRACE HF: Empagliflozin Cuts PA Pressure in HF With or Without Diabetes

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

As Interventions Dip During COVID-19, CMS Offers Leniency on Volumes

In MITRA-FR, ‘Disproportionate’ MR Theory Doesn’t Pan Out

James T. Willerson, Revered Clinician, Editor, and Mentor, Dies at 81

TCTMD’s Top 10 Most Popular Stories for July 2020

Too Many HF Trial Results Underreported or Never Published

MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

TCTMD’s Top 10 Most Popular Stories for February 2020

TCTMD’s Top 10 Most Popular Stories for January 2020

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

The Biggest News of 2019: TCTMD’s Top 10

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content